ArticleHuman vaccines & immunotherapeutics2020

Tumor membrane-based vaccine immunotherapy in combination with anti-CTLA-4 antibody confers protection against immune checkpoint resistant murine triple-negative breast cancer.

Christopher D Pack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.